Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech is returning with its advanced proprietary high-yield expression technologies to Europe’s leading pharma industry event, the CPHI Worldwide trade expo, hosted in Milan for 2024.
enGenes will again attend CPHI as a visitor, with its team, including Mr. Karl Hübler, lead of the Business Development team, networking across the show.
Enhanced production opportunities
“We were very impressed with CPHI Worldwide on our debut at last year’s Barcelona expo and delighted with the number of new conversations we were able to start there,” said CEO and co-founder Dr. Jürgen Mairhofer.
To find out more, visit https://www.pharmaceutical-networking.com/engenes-biotech-returning-to-cphi-worldwide-in-milan/
Comments